Investigations on Factors Affecting Chitosan for Dissolution Enhancement of Oxcarbazepine by Spray Dried Microcrystal Formulation With an Experimental Design Approach

REFERENCES

• Abberger T., Seo A., Schaefer T. The effect of droplet size and powder particle size on the mechanisms of nucleation and growth in fluid bed melt agglomeration. Int. J. Pharm. 2002; 249: 185–197
   PubMed Web of Science ®Google Scholar
• Acarturk F., Sencan A., Celebi N. Enhancement of the dissolution of spironolactone with chitosan and low molecular weight gelatin. STP Pharma. Sci. 1993a; 3: 369–373
   Google Scholar
• Acarturk F., Sencan A., Celebi N. Evaluation of the effect of low molecular weight chitosan on the solubility and dissolution characteristics of spironolactone. Pharmazie. 1993b; 48: 605–607
   Web of Science ®Google Scholar
• Adler M., Lee G. Stability and surface activity of lactate dehydrogenase in spray dried trehalose. J. Pharm., Sci. 1999; 88: 199–208
   PubMed Web of Science ®Google Scholar
• Ambike A. A., Mahadik K. R., Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations. Pharm. Res. 2005; 22: 990–998
   PubMed Web of Science ®Google Scholar
• Asada M., Takahashi H., Okamoto H., Tanino H., Danjo K. Theophylline particle design using chitosan by the spray drying. Int. J. Pharm. 2004; 270: 167–174
   PubMed Web of Science ®Google Scholar
• Bodek K. H. Effect of microcrystalline chitosan on the solubility of ibuprofen. Acta Pol Pharm. 2002; 59: 105–108
   PubMedGoogle Scholar
• Byrn S. R., Xu W., Newman A. W. Chemical reactivity in solid-state Pharm.aceuticals: formulation implications. Adv. Drug Deliv. Rev. 2001; 48: 115–136
   PubMed Web of Science ®Google Scholar
• Chidavaenzi O. C., Buckton G., Koosha F. The effect of co-spray drying with polyethylene glycol 4000 on the crystallinity and physical form of lactose. Int. J. Pharm. 2001; 216: 43–49
   PubMed Web of Science ®Google Scholar
• Christensen K. L., Pedersen G. P., Kristensen H. G. Preparation of redispersible dry emulsions by spray drying. Int. J. Pharm. 2001; 212: 187–194
   PubMed Web of Science ®Google Scholar
• Cilurzo F., Minghetti P., Casiraghi A., Montanari L. Characterization of nifedipine solid dispersions. Int. J. Pharm. 2002; 242: 313–317
   PubMed Web of Science ®Google Scholar
• Corrigan O. I. Thermal analysis of spray dried products. Thermo. Acta 1995; 248: 245–258
   Web of Science ®Google Scholar
• Corrigan D. O., Healy A. M., Corrigan O. I. The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties. Int. J. Pharm. 2002; 235: 193–205
   PubMed Web of Science ®Google Scholar
• Doherty C., York P. The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions. J. Pharm. Pharmacol. 1989; 41: 73–78
   PubMed Web of Science ®Google Scholar
• Feeley J. C., York P., Sumby B. S., Dicks H. Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation. Int. J. Pharm. 1998; 172: 89–96
   Web of Science ®Google Scholar
• Giunchedi P., Gavini E., Palmieri G. F., Bonacucina G. Tabletted polylactide microspheres prepared by a w/o emulsion – spray drying method. J. Microencapsul. 2000; 17: 711–720
   PubMed Web of Science ®Google Scholar
• Giunchedi P., Juliano C., Gavini E., Cossu M., Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microspheres. Eur. J. Pharm. Biopharm. 2002; 53: 233–239
   PubMed Web of Science ®Google Scholar
• Gohel M. C., Patel L. D. Processing of nimesulide-PEG 400-PG-PVP solid dispersions: preparation, characterization, and in vitro dissolution. Drug Dev. Ind. Pharm. 2003; 29: 299–310
   PubMed Web of Science ®Google Scholar
• Hancock B. C., Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 1997; 86: 1–12
   PubMed Web of Science ®Google Scholar
• Hou W. M., Miyazaki S., Takada M., Komai T. Sustained release of indomethacin from chitosan granules. Chem. Pharm. Bull. 1985; 33: 3986–3992
   PubMed Web of Science ®Google Scholar
• Ishikawa T., Watanabe Y., Takayama K., Endo H., Matsumoto M. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int. J. Pharm. 2000; 202: 173–178
   PubMed Web of Science ®Google Scholar
• Kapsi S. G., Ayres J. W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int. J. Pharm. 2001; 229: 193–203
   PubMed Web of Science ®Google Scholar
• Kaushal A. M., Gupta P., Bansal A. K. Amorphous Drug Delivery Systems: Molecular Aspects, Design and Performance. Crit. Rev. Therap. Drug Carri. Syst. 2004; 21: 133–193
   PubMedGoogle Scholar
• Lian Y. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Deliv. Rev. 2001; 48: 27–42
   PubMed Web of Science ®Google Scholar
• Lobenberg R., Amidon G. L. Modern bioavailability, bioequivalence and and biopharmaceutics classification system: new scientific approaches to international regulatory standards. Eur J Pharm. Biopharm. 2000; 50: 3–12
   PubMed Web of Science ®Google Scholar
• Mashru R. C., Sutariya V. B., Sankalia M. G., Sankalia J. M., Parikh P. P. Development and evaluation of fast dissolving film of salbutamol sulphate. Drug Dev. Ind. Pharm. 2005; 1: 25–34
   Google Scholar
• Maury M., Murphy K., Kumar S., Shi L., Lee G. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer. Eur. J. Pharm. Biopharm. 2005; 59: 565–573
   PubMed Web of Science ®Google Scholar
• Menon A., Dhodi N., Mandella W., Chakrabarti S. Identifying fluid bed parameters affecting product variability. Int. J. Pharm. 1996; 140: 207–218
   Web of Science ®Google Scholar
• Mitchell S. A., Reynolds T. D., Dasbach T. P. A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose. Int. J. Pharm. 2003; 250: 3–11
   PubMed Web of Science ®Google Scholar
• Nazzal S., Nutan M., Palamakula A., Shah R., Zaghloul A., Khan M. A. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int. J. Pharm. 2002; 240: 103–114
   PubMed Web of Science ®Google Scholar
• http://www.ukdipg.org.uk/stage4.htm Oxcarbazepine. New medicines on the market Produced by the UK Medicines Information Pharmacists Group (Aug 2000)
   Google Scholar
• Paradkar A. R., Ambike A. A., Jadhav B. K., Mahadik K. R. Characterization of curcumin-pvp solid dispersions obtained by spray drying. Int. J. Pharm. 2004; 271: 281–286
   PubMed Web of Science ®Google Scholar
• Portero A., Remun˜an-Lopez C., Vila-Jato J. L. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int. J. Pharm. 1998; 175: 75–84
   Web of Science ®Google Scholar
• Qi R., Ping Q. N. Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats. J. Microencapsul. 2004; 21: 37–45
   PubMed Web of Science ®Google Scholar
• Rambali B., Baert L., Massart D. L. Using experimental design to optimize the process parameters in a fluid bed granulation on a semi-full scale. Int. J. Pharm. 2001; 220: 149–160
   PubMed Web of Science ®Google Scholar
• Rasenack N., Hartenhauer H., Muller B. W. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm. 2003; 254: 137–145
   PubMed Web of Science ®Google Scholar
• Rasenack N., Muller B. W. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm. Res. 2002; 19: 1894–1900
   PubMed Web of Science ®Google Scholar
• Ritthidej G. C., Chomto P., Pummangura S., Menasveta P. Chitin and chitosan as disintegrants in paracetamol tablets. Drug Dev. Ind. Pharm. 1994; 20: 2109–2134
   Web of Science ®Google Scholar
• Rotthäuser B., Kraus G., Schmidt P. C. Optimization of an effervescent tablet formulation using a central composite design optimization of an effervescent tablet formulation containing spray dried L-leucine and polyethylene glycol 6000 as lubricants using a central composite design. Eur. J. Pharm. Biopharm. 1998; 46: 85–94
   PubMed Web of Science ®Google Scholar
• Sawayanagi Y., Nambu N., Nagai T. Dissolution properties and bioavailability of griseofulvin from ground mixtures with chitin or chitosan. Chem. Pharm. Bull. 1982; 30: 4454–4467
   Google Scholar
• Sawayanagi Y., Nambu N., Nagai T. Dissolution properties and bioavailability of phenytoin from ground mixtures with chitin or chitosan. Chem. Pharm. Bull. 1983; 31: 2062–2068
   Google Scholar
• Schott H. Colloidal dispersions. The Philadelphia College of Pharmacy and Science, Philadelphia 1985
   Google Scholar
• Sertsou G., Butler J., Scott A., Hempenstall J., Rades T. Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation. Int. J. Pharm. 2002; 245: 99–108
   PubMed Web of Science ®Google Scholar
• Shiraishi S., Arahira M., Imai T., Otagiri M. Enhancement of dissolution rates of several drugs by low molecular chitosan and alginate. Chem. Pharm. Bull. 1990; 38: 185–187
   Web of Science ®Google Scholar
• Upadrashta S. M., Katikaneni P. R., Nuessle N. O. Chitosan as a tablet binder. Drug Dev. Ind. Pharm. 1992; 18: 1701–1708
   Web of Science ®Google Scholar
• Vertommen J., Kinget R. The influence of five selected processing and formulation variables on the particle size, particle size distribution and friability of pellets produced in a rotary processor. Drug Dev. Ind. Pharm. 1997; 23: 39–46
   Web of Science ®Google Scholar
• Wiedmann T. S., DeCastro L., Wood R. W. Nebulization of NanoCrystals™: Production of a Respirable Solid-in-Liquid-in-Air Colloidal Dispersion. Pharm. Res. 1997; 14: 112–116
   PubMed Web of Science ®Google Scholar
• Yamada T., Saito N., Anraku M., Imai T., Otagiri M. Physicochemical characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N, N -dimethylcarbamoy-loxy)- 5H-benzofuro [3,2-c] quinoline-6- one (KCA-098) by solid dispersion with hydroxypropylcellulose. Pharm. Dev. Technol. 2000; 5: 443–454
   PubMed Web of Science ®Google Scholar
• Yu L. X., Amidon G. L., Polli J. E., Zhao H., Mehta M. U., Conner D. P., Shah V. P., Lesko L. J., Chen M. L., Lee V. H., Hussain A. S. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm. Res. 2002; 19: 921–925
   PubMed Web of Science ®Google Scholar